| Specificity and transcriptional activity of microbiota associated with low and high microbial abundance sponges from the Red Sea L Moitinho‐Silva, K Bayer, CV Cannistraci, EC Giles, T Ryu, L Seridi, ... Molecular ecology 23 (6), 1348-1363, 2014 | 147 | 2014 |
| Molecular processes of transgenerational acclimation to a warming ocean HD Veilleux, T Ryu, JM Donelson, L Van Herwerden, L Seridi, Y Ghosheh, ... Nature Climate Change 5 (12), 1074-1078, 2015 | 139 | 2015 |
| Hologenome analysis of two marine sponges with different microbiomes T Ryu, L Seridi, L Moitinho-Silva, M Oates, YJ Liew, C Mavromatis, ... BMC genomics 17, 1-11, 2016 | 77 | 2016 |
| Revealing microbial functional activities in the Red Sea sponge Stylissa carteri by metatranscriptomics L Moitinho‐Silva, L Seridi, T Ryu, CR Voolstra, T Ravasi, U Hentschel Environmental Microbiology 16 (12), 3683-3698, 2014 | 75 | 2014 |
| Characterization of piRNAs across postnatal development in mouse brain Y Ghosheh, L Seridi, T Ryu, H Takahashi, V Orlando, P Carninci, T Ravasi Scientific reports 6 (1), 25039, 2016 | 38 | 2016 |
| Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus RF van Vollenhoven, KC Kalunian, T Dörner, BH Hahn, Y Tanaka, ... Annals of the rheumatic diseases 81 (11), 1556-1563, 2022 | 35 | 2022 |
| The evolution of ultraconserved elements with different phylogenetic origins T Ryu, L Seridi, T Ravasi BMC evolutionary biology 12, 1-11, 2012 | 34 | 2012 |
| Nuclear AGO1 regulates gene expression by affecting chromatin architecture in human cells M Shuaib, KM Parsi, M Thimma, SA Adroub, H Kawaji, L Seridi, ... Cell systems 9 (5), 446-458. e6, 2019 | 30 | 2019 |
| Transcriptome analysis elucidates key developmental components of bryozoan lophophore development YH Wong, T Ryu, L Seridi, Y Ghosheh, S Bougouffa, PY Qian, T Ravasi Scientific reports 4 (1), 6534, 2014 | 24 | 2014 |
| Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome L Seridi, GC Leo, GL Dohm, WJ Pories, J Lenhard PLoS One 13 (5), e0198156, 2018 | 21 | 2018 |
| Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks, K Ma, ... Arthritis & Rheumatology 73 (3), 472-477, 2021 | 19 | 2021 |
| Transcriptome and proteome dynamics in larvae of the barnacle Balanus Amphitrite from the Red Sea KH Chandramouli, S Al-Aqeel, T Ryu, H Zhang, L Seridi, Y Ghosheh, ... BMC genomics 16, 1-17, 2015 | 16 | 2015 |
| Dynamic epigenetic control of highly conserved noncoding elements L Seridi, T Ryu, T Ravasi PLoS One 9 (10), e109326, 2014 | 10 | 2014 |
| First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial J Jordan, J Benson, WW Chatham, RA Furie, W Stohl, JCC Wei, ... The Lancet Rheumatology 2 (10), e613-e622, 2020 | 5 | 2020 |
| Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition L Seridi, M Cesaroni, A Orillion, J Schreiter, M Chevrier, S Marciniak, ... Lupus 30 (5), 795-806, 2021 | 4 | 2021 |
| Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks Arthritis Rheumatol 73 (3), 10.1002, 2020 | 3 | 2020 |
| OP0278 biomarker profiling reveals novel mechanistic insights into ustekinumab therapeutic responses in systemic lupus erythematosus M Cesaroni, L Seridi, J Jordan, K Sweet, MA Keying, C Franks, J Schreiter, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 220-221, 2019 | 3 | 2019 |
| AGO1 in association with NEAT1 lncRNA contributes to nuclear and 3D chromatin architecture in human cells M Shuaib, KM Parsi, H Kawaji, M Thimma, SA Adroub, A Fort, Y Ghosheh, ... bioRxiv, 525527, 2019 | 3 | 2019 |
| OP0161 association of baseline cytotoxic gene expression with ustekinumab response in systemic lupus erythematosus L Seridi, M Cesaroni, MJ Loza, J Schreiter, K Sweet, Y Orlovsky, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 101-102, 2020 | 2 | 2020 |
| 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus J Jordan, K Sweet, M Cesaroni, K Ma, C Franks, L Seridi, J Schreiter, ... Lupus Science & Medicine 6 (Suppl 1), 2019 | 2 | 2019 |
Lucas Moitinho-SilvaChristian-Albrechts-University Kiel and University Hospital Schleswig-HolsteinVerifierad e-postadress på ikmb.uni-kiel.de
